Jinsan Kim
CEO · Strategy & venture executionKAIST bioengineering. Strategy at Daesang and Samsung Fine Chemicals, VC investment at Moohan, executive vice president at Enbion — a career spent moving chemistry from lab to business.
The team is structured around the work required to move carbon chemistry beyond the lab: capture, synthesis, process control, and commercial execution.
KAIST bioengineering. Strategy at Daesang and Samsung Fine Chemicals, VC investment at Moohan, executive vice president at Enbion — a career spent moving chemistry from lab to business.
PhD in applied organic chemistry, Karlsruhe (Germany). Researcher at KRICT and SK Innovation; research director at Finecera and Chembio — owns the LEP™ process window.
PhD in organic chemistry, Pittsburgh. Principal researcher at Samsung Advanced Institute of Technology; CTO at COS Biotech, CEO at Medigen — leads catalyst and monomer chemistry.
Chemical engineering, Hanyang. Ssangyong Cement central research, then CEO of Enbion — 25 years of industrial adsorption engineering behind the RCC capture pathway.